TARGETING FLT3 WITH CHIMERIC ANTIGEN RECEPTOR T CELLS CONFERS POTENT REACTIVITY AGAINST ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Jetani, H. [1 ]
Garcia-Cadenas, I. [2 ]
Nerreter, T. [1 ]
Sierra, J. [2 ]
Herr, W. [3 ]
Thomas, S. [3 ]
Einsele, H. [1 ]
Hudecek, M. [1 ]
机构：
[1] Univ Hosp Wurzburg, Internal Med 2, Wurzburg, Germany
[2] Hosp Santa Creu & Sant Pau, Serv Hematol, Barcelona, Spain
[3] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 3, Regensburg, Germany
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S145
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [41] FLT3 chimeric antigen receptor T cell therapy induces B to T cell lineage switch in infant acute lymphoblastic leukemia
    Chien, Christopher D.
    Yang, Lila
    Nguyen, Sang M.
    Sauter, Christopher T.
    Ishii, Kazusa
    Shen, Feng
    Tasian, Sarah K.
    Fry, Terry J.
    CANCER RESEARCH, 2018, 78 (13)
  • [42] Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
    Gill, Saar
    Tasian, Sarah K.
    Ruella, Marco
    Shestova, Olga
    Li, Yong
    Porter, David L.
    Carroll, Martin
    Danet-Desnoyers, Gwenn
    Scholler, John
    Grupp, Stephan A.
    June, Carl H.
    Kalos, Michael
    BLOOD, 2014, 123 (15) : 2343 - 2354
  • [43] Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia
    Yu, Wei
    Zhang, Hang
    Yuan, Yuncang
    Tang, Jie
    Chen, Xinchuan
    Liu, Ting
    Zhao, Xudong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [44] Chimeric antigen receptor T cell therapies for acute myeloid leukemia
    Bin Gu
    Jianhong Chu
    Depei Wu
    Frontiers of Medicine, 2020, 14 : 701 - 710
  • [45] Gilteritinib Reduces FLT3 Expression in Acute Myeloid Leukemia Cells
    Thai, Thi Lam
    Han, Sun-Young
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (05) : 577 - 581
  • [46] Chimeric antigen receptor T cell therapies for acute myeloid leukemia
    Gu, Bin
    Chu, Jianhong
    Wu, Depei
    FRONTIERS OF MEDICINE, 2020, 14 (06) : 701 - 710
  • [47] MESOTHELIN TARGETING CHIMERIC ANTIGEN RECEPTOR THERAPY FOR PEDIATRIC ACUTE MYELOID LEUKEMIA
    Fong, Christina
    Misawa, Kyohei
    Vista, William Ray
    Banerjee, Srijita
    Adusumilli, Prasad S.
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [48] Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression
    Zhang, Dengyang
    Guo, Yao
    Zhao, Yuming
    Yu, Liuting
    Chang, Zhiguang
    Pei, Hanzhong
    Huang, Junbin
    Chen, Chun
    Xue, Hongman
    Xu, Xiaojun
    Pan, Yihang
    Li, Ningning
    Zhu, Chengming
    Zhao, Zhizhuang Joe
    Yu, Jian
    Chen, Yun
    MICROBIAL CELL FACTORIES, 2021, 20 (01)
  • [49] Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia
    Jarusiewicz, Jamie A.
    Jeon, Jae Yoon
    Connelly, Michele C.
    Chen, Yizhe
    Yang, Lei
    Baker, Sharyn D.
    Guy, R. Kiplin
    ACS OMEGA, 2017, 2 (05): : 1985 - 2009
  • [50] Single and Dual Targeting Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia
    Chitre, Sneha
    Gaken, Joop
    Venuso, Andrea
    Mufti, Ghulam J.
    BLOOD, 2020, 136
12345